This REIT Could Be The Next Realty Income! | Agree Realty Corporation (ADC) Stock Analysis! |
1 extracted signal · 0 resolved · 1 still active
DividendologyIndependent analyst profile- Source published
- 29 Sept 2026, 13:55 UTC
- Recorded by Tahlil Plus
- 29 Sept 2026, 16:55 UTC

AI-generated source summary
Agree Realty Corporation (ADC) exhibits strong financial health with a robust dividend growth strategy and a fortress balance sheet, characterized by minimal debt maturities until 2028. The company's forward-looking guidance shows a significant increase in AFFO per share, indicating sustained earnings growth. Analyst ratings are predominantly 'Strong Buy,' with a consensus 12-month price target suggesting approximately 23.05% upside potential from the current price. The dividend discount model, assuming a 4.50% growth rate, values the stock at $80.49, indicating a substantial undervaluation compared to the current market price. Furthermore, the company's active acquisition strategy, with a weighted-average capitalization rate of 7.0%, is a primary driver of its growth, supported by a strong investment grade rating and a well-managed debt-to-asset ratio. These fundamental strengths suggest a bullish outlook for ADC, despite recent market headwinds affecting REITs.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Dividendology
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
